Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Lavoué V, Huchon C, Daraï E. Should hyperthermic intraperitoneal chemotherapy be the new standard of care in ovarian cancer? J Gynecol Obstet Hum Reprod 2018;47:497. [PMID: 30243805 DOI: 10.1016/j.jogoh.2018.09.005] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2018] [Revised: 09/11/2018] [Accepted: 09/18/2018] [Indexed: 12/01/2022]

For:	Lavoué V, Huchon C, Daraï E. Should hyperthermic intraperitoneal chemotherapy be the new standard of care in ovarian cancer? J Gynecol Obstet Hum Reprod 2018;47:497. [PMID: 30243805 DOI: 10.1016/j.jogoh.2018.09.005] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2018] [Revised: 09/11/2018] [Accepted: 09/18/2018] [Indexed: 12/01/2022]

Number	Cited by Other Article(s)
1	HIPEC in advanced epithelial ovarian cancer: why is there controversy? Curr Opin Oncol 2020;32:451-458. [DOI: 10.1097/cco.0000000000000659] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse
2	Saved by the evidence: Hyperthermic intraperitoneal chemotherapy still has a role to play in ovarian cancer. Eur J Surg Oncol 2019;45:1757-1759. [DOI: 10.1016/j.ejso.2019.03.037] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2019] [Accepted: 03/26/2019] [Indexed: 01/25/2023] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse
3	Lavoué V, Bendifallah S, Collinet P, Graesslin O, Ballester M, Akladios C, Carcopino X, Bricou A, Koskas M, Canlorbe G, Coutant C, Bolze PA, Ouldamer L, Daraï E, Touboul C, Huchon C. La chimiothérapie hyperthermique intra-péritonéale (CHIP) sauvée par les preuves : la carcinose ovarienne, cible privilégiée de la CHIP ? Bull Cancer 2019;106:175-178. [DOI: 10.1016/j.bulcan.2018.12.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2018] [Revised: 11/26/2018] [Accepted: 12/03/2018] [Indexed: 10/27/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse